GLP-1 drugsHumans704 participants1 yearCohort study

Outcomes of GLP-1 Receptor Agonist Therapy after Liver Transplantation in Patients with Type 2 Diabetes: A Real-World Cohort Study

Journal of Gastrointestinal and Liver Diseases

The paper

Guy Nguefang, Sarpong Boateng, Solomon Gyabaah,

Joel Gabin Konlack, Yussif Issaka, Edgar Luna Landa, Tracy Chukwu, Elvis Eze,

Texas Tech University Health Sciences Center · Euclid University

Journal of Gastrointestinal and Liver Diseases · 26 Sep 2026

doi.org/10.15403/jgld-6863 PubMed 42803248

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
Semaglutide curbs kidney vascular resistance and fibrosis
Nature Medicine · 4 Oct 2026